Crohn’s Research

Crohn's ResearchIn this section, you can find out all about the Crohn’s research that forCrohns funds. Our mission is to fund research that helps those with the condition today and contributes to finding a cure for Crohn’s Disease in the future. One day we will beat Crohn’s Disease. The more research we do, the sooner that day will come.

To date we have invested over £400,000 into Crohn’s Disease research covering a wide variety of studies into the disease. These include investigations leading to a greater understanding of the condition, diagnosis, symptoms, treatments and psychological impact.

Our policy is to fund research at universities and hospitals throughout the UK and all awards are vetted and approved by the forCrohns trustees and panel of doctors.

forCrohns and the charity ‘Core’ recently announced a joint grant call for research projects on Crohn’s Disease.  Applications are invited for a grant of up to £50,000 for a scientific research project on Crohns Disease. The research question should reflect at least one of the top ten research priorities identified in the James Lind Alliance Priority Setting Partnership on Inflammatory Bowel Disease.

The grant call is open to established investigators, both clinicians and scientists, based at a UK university or hospital. Academic Clinical Lecturers who have a contract of sufficient length to cover the duration of the research project will be considered. This award is not for a fellowship; the principal applicant must have an established academic or clinical position though co-applicants may be fellows. Funding will be available only in the UK.

The deadline for applications is 5pm 19 January 2018 and the awards will be decided in March/April. For further information and to apply click here.

You can find out details of some of the projects we have funded since 2008 here:

2017

2016

2015

2014

2013

2012

2010

2008

forCrohns is the only charity in the UK solely dedicated to funding research into and raising awareness of Crohn’s Disease.